| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,557 |
2,452 |
$305K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,184 |
2,058 |
$300K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,606 |
1,502 |
$166K |
| 70450 |
Computed tomography, head or brain; without contrast material |
238 |
222 |
$83K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
72 |
70 |
$31K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
59 |
56 |
$20K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
273 |
182 |
$15K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
93 |
90 |
$12K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
449 |
419 |
$12K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
12 |
12 |
$8K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
58 |
53 |
$5K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
68 |
60 |
$3K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
15 |
15 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
174 |
157 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
44 |
40 |
$2K |
| 80053 |
Comprehensive metabolic panel |
1,595 |
1,438 |
$1K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
227 |
213 |
$723.71 |
| 71045 |
Radiologic examination, chest; single view |
514 |
480 |
$640.90 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
547 |
483 |
$504.98 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
589 |
562 |
$354.48 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
205 |
198 |
$213.48 |
| 71046 |
Radiologic examination, chest; 2 views |
14 |
13 |
$188.27 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
194 |
134 |
$110.24 |
| 36415 |
Collection of venous blood by venipuncture |
1,446 |
1,171 |
$57.25 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,742 |
1,545 |
$55.38 |
| 87428 |
|
54 |
53 |
$54.11 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
274 |
251 |
$50.90 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
715 |
582 |
$44.13 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
17 |
12 |
$36.46 |
| 84702 |
|
21 |
14 |
$16.20 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
57 |
54 |
$11.33 |
| 80061 |
Lipid panel |
110 |
106 |
$5.17 |
| 81001 |
|
390 |
358 |
$3.62 |
| 81025 |
|
249 |
233 |
$3.61 |
| 82962 |
|
131 |
67 |
$3.29 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
46 |
44 |
$3.15 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
356 |
267 |
$0.32 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
55 |
51 |
$0.00 |
| 81003 |
|
257 |
235 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
19 |
15 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
151 |
144 |
$0.00 |
| 85610 |
|
206 |
188 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
74 |
53 |
$0.00 |
| 86900 |
|
21 |
15 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
25 |
24 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$0.00 |
| 83690 |
|
191 |
180 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
360 |
330 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
16 |
16 |
$0.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
29 |
26 |
$0.00 |
| 84484 |
|
402 |
210 |
$0.00 |
| 85730 |
|
131 |
120 |
$0.00 |
| 84703 |
|
29 |
28 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
141 |
126 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
58 |
56 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
249 |
222 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
16 |
15 |
$0.00 |
| 83735 |
|
158 |
124 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
171 |
120 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
44 |
40 |
$0.00 |
| 83605 |
|
26 |
24 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
15 |
14 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
15 |
15 |
$0.00 |
| 86901 |
|
21 |
15 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
14 |
14 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
22 |
18 |
$0.00 |